The MMRF has built a global clinical network of research institutions and cancer centers with the goal of taking all the data and learning being generated in myeloma and using it to drive more precise treatments to patients faster.
About the MMRC
The Multiple Myeloma Research Consortium is speeding molecularly targeted therapies, immune therapies and novel therapies to trial.LEARN MORE
Drugs Brought to Market
Before the MMRF, there were no new treatments for decades. Today, myeloma has seen more drugs approved than any other cancer. Currently there are 10 FDA approved drugs on the market.LEARN MORE
MMRC Clinical Trials
The MMRC conducts trials of molecularly targeted drugs, immune therapy agents, and novel mechanisms. We typically open trials 60% faster than the industry average.LEARN MORE